Johanna RossellSenior Vice President, General Manager, Rare Disease at Sumitomo PharmaSpeaker
As Senior Vice President, General Manager, Rare Disease, at Sumitomo Pharma America, Johanna oversees commercial activities for RETHYMIC® and leads the company’s efforts to make this groundbreaking regenerative medicine available to more patients. She also provides leadership for Sumitomo Pharma America’s growth strategies in rare disease, including expansions into new geographies.
With broad and deep background across consumer goods and healthcare categories in the U.S. and several geographies around the world, Johanna brings a unique and nuanced perspective to long-term strategic planning. She has led multifunctional teams delivering strong business results for companies such as Procter & Gamble, Novartis, Merck, Mallinckrodt and Biogen. She has had extensive success leading new products to the U.S. market and creating integrated pre- and post-launch commercial plans, both in the U.S. and globally, including a Regenerative Medicine Advanced Therapy (RMAT)-designated tissue-based product and several therapies for rare diseases.
Johanna received a Bachelor of Science in Computer Engineering and an MBA from Simon Bolivar University in Caracas, Venezuela.